Published Oct 5, 2022
A New Drug For A Relentless Brain Disease
Explore the groundbreaking yet controversial FDA approval of Relyvrio, a new ALS drug born from the tenacity of its founders Josh Cohen and Justin Klee, fueled by public advocacy and innovative fundraising, offering a glimmer of hope to those battling this relentless disease despite limited evidence.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
A Brand New Kind of Schizophrenia Treatment
Answers 383 questions
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
Answers 383 questionsDepression And Alzheimer's Treatments At A Crossroads
Answers 383 questions
New Tech Targets Epilepsy With Lasers, Robots
Answers 383 questions
What A New Antiviral Drug Could Mean For The Future Of COVID
Answers 383 questionsHelping A Man Walk Again With Science
Answers 383 questionsThe Evolution Of HIV Treatment
Answers 383 questionsA new step toward ending 'the wrath of malaria'
Answers 383 questions
One More Step Toward Solving The Sleep & Alzheimer's Puzzle
Answers 383 questions
A COVID-19 Vaccine: What You Need To Know
Answers 383 questions
A Revolutionary Experiment To Edit Human Genes
Answers 383 questionsA Newly-Discovered Asteroid And What's Beneath The Ice On Enceladus
Answers 383 questionsThat Revolutionary Gene-Editing Experiment? So Far So Good.
Answers 383 questions
The opioid epidemic
Answers 383 questionsAre We On The Brink Of A Nuclear Fusion Breakthrough?
Answers 383 questions